Biostat Biologx
Degenerative Disc Disease
Spinal Restoration, Inc.Phase 3Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 89/ 100
Competitive context
7 Active assets in the Degenerative Disc Disease cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
NEPENTHE Brigham and Women's Hospital | Phase 4 | BB |
Oxycodone Brigham and Women's Hospital | Phase 4 | BB |
AUTOLOGOUS CONDITIONED PLASMA Allmed Medical Center | Phase 2 | BB |
Rexlemestrocel-L Mesoblast, Ltd. | Phase 3 | BB |
Single Dose Mpcs Mesoblast, Ltd. | Phase 2 | B |
View all 11 →
Same molecule, other indications
Biostat Biologx is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →